Fractyl Health Inc. GUTS
Super Investor & Insider
1
Fondi che lo detengono
#1274
Rank consenso
1.4%
% dei portafogli
$1.8M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 0.02% | Reduce 6.44% | 3,974,806 | $1.8M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Fractyl Health Inc. is a biotechnology company focused on developing advanced treatments for chronic metabolic and inflammatory diseases. The company's primary endeavor is to transform the treatment landscape of type 2 diabetes and related metabolic disorders by targeting the underlying causes rather than merely managi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees100
TickerGUTS
Statistics
Market Cap$135.1M
Revenue (TTM)$0
Net Income-$141.0M
Net Margin—
EPS$-1.86
P/E-0.80
P/S—
P/B5.42
EV/EBITDA-1.24
ROE-778.3%
Dividend Yield—
Price$0.85
Data: Twelve Data · Revenue = mcap / P/S